Intolerance to SGLT2 Inhibitors
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70Copied!
Version20220716Copied!
PublisherAHA StewardDate2022-07-16T01:02:12-04:00Purpose(Clinical Focus: The purpose of this value set is to represent concepts of a diagnosis of an intolerance to SGLT2 inhibitors.),(Data Element Scope: This value set may use a model element related to Diagnosis.),(Inclusion Criteria: Includes concepts that represent a diagnosis of an intolerance to SGLT2 inhibitors.),(Exclusion Criteria: No exclusions.)
Expansion
No concepts found
systemhttp://snomed.info/sct
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://snomed.info/sct",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 5
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2022-07-16T01:02:12-04:00",
"meta" : {
"versionId" : "8",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "AHA Steward",
"jurisdiction" : [ {
"coding" : [ {
"system" : "urn:iso:std:iso:3166",
"code" : "US"
} ]
} ],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of a diagnosis of an intolerance to SGLT2 inhibitors.),(Data Element Scope: This value set may use a model element related to Diagnosis.),(Inclusion Criteria: Includes concepts that represent a diagnosis of an intolerance to SGLT2 inhibitors.),(Exclusion Criteria: No exclusions.)",
"name" : "IntoleranceToSGLT2Inhibitors",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://snomed.info/sct",
"code" : "470701000124108",
"display" : "Adverse reaction to substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (disorder)",
"version" : "http://snomed.info/sct/731000124108/version/20240901"
}, {
"system" : "http://snomed.info/sct",
"code" : "471751000124101",
"display" : "Adverse reaction caused by canagliflozin (disorder)",
"version" : "http://snomed.info/sct/731000124108/version/20240901"
}, {
"system" : "http://snomed.info/sct",
"code" : "471761000124104",
"display" : "Adverse reaction caused by dapagliflozin (disorder)",
"version" : "http://snomed.info/sct/731000124108/version/20240901"
}, {
"system" : "http://snomed.info/sct",
"code" : "471771000124106",
"display" : "Adverse reaction caused by ertugliflozin (disorder)",
"version" : "http://snomed.info/sct/731000124108/version/20240901"
}, {
"system" : "http://snomed.info/sct",
"code" : "471791000124107",
"display" : "Adverse reaction caused by empagliflozin (disorder)",
"version" : "http://snomed.info/sct/731000124108/version/20240901"
} ],
"total" : 5,
"identifier" : "urn:uuid:3da39ef9-2368-44d7-b21d-ff4500b20a08",
"timestamp" : "2024-12-10T07:30:15-05:00"
},
"title" : "Intolerance to SGLT2 Inhibitors",
"extension" : [ {
"valueContactDetail" : {
"name" : "AHA Author"
},
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2024-01-24",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2022-07-16",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "58c6731b-073f-494d-9af0-82f8d880f3d6",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1178.70"
} ],
"version" : "20220716"
}